Literature DB >> 16383214

Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease.

Bonnie E Levin1, Heather L Katzen.   

Abstract

Early cognitive changes in patients with PD are often subtle and influenced by factors that interact with the disease process, including age of disease onset, medication, and the specific constellation of motor symptoms. These factors notwithstanding, ample evidence exists that specific cognitive changes occur early in the course of PD. This evidence does not imply that cognitive deficits are pervasive during the early stages. To the contrary, they are usually subtle and often difficult to detect without formal neuropsychological testing. Executive-function deficits are the most frequently reported cognitive problems and, given that executive skills are an integral part of many tasks, it follows that subtle difficulties may be seen on a wide range of cognitive measures, particularly in working memory and visuospatial dysfunction, two areas that rely heavily on executive skills. Whereas apraxia and language processing deficits occur infrequently, subtle changes in olfaction and contrast sensitivity have also been repeatedly observed. Finally, depressive symptoms are also common in the early stages of the disease. The significance of the early behavioral changes and their prognostic implications are largely unknown. Prospective studies are needed to understand the longitudinal course of early cognitive changes to determine whether they remain as circumscribed impairments or represent a precursor to a more widespread dementia.

Entities:  

Mesh:

Year:  2005        PMID: 16383214

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  14 in total

1.  Memory Similarities Between Essential Tremor and Parkinson's Disease: A Final Common Pathway?

Authors:  Jacob A Lafo; Jacob D Jones; Michael S Okun; Russell M Bauer; Catherine C Price; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2015-12-21       Impact factor: 3.535

Review 2.  Preservation of function in Parkinson's disease: what's learning got to do with it?

Authors:  Jeff A Beeler
Journal:  Brain Res       Date:  2011-09-29       Impact factor: 3.252

3.  Restriction of dopamine signaling to the dorsolateral striatum is sufficient for many cognitive behaviors.

Authors:  Martin Darvas; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

4.  Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation.

Authors:  Hideo Mure; Chris C Tang; Miklos Argyelan; Maria-Felice Ghilardi; Michael G Kaplitt; Vijay Dhawan; David Eidelberg
Journal:  J Neurosci       Date:  2012-02-22       Impact factor: 6.167

5.  Recognition of emotions from visual and prosodic cues in Parkinson's disease.

Authors:  Alessandra Ariatti; Francesca Benuzzi; Paolo Nichelli
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

6.  Early Parkinson's disease: longitudinal changes in brain activity during sequence learning.

Authors:  Maren Carbon; Kathrin Reetz; M Felice Ghilardi; Vijay Dhawan; David Eidelberg
Journal:  Neurobiol Dis       Date:  2009-11-10       Impact factor: 5.996

Review 7.  Glycoproteomics in neurodegenerative diseases.

Authors:  Hyejin Hwang; Jianpeng Zhang; Kathryn A Chung; James B Leverenz; Cyrus P Zabetian; Elaine R Peskind; Joseph Jankovic; Zhen Su; Aneeka M Hancock; Catherine Pan; Thomas J Montine; Sheng Pan; John Nutt; Roger Albin; Marla Gearing; Richard P Beyer; Min Shi; Jing Zhang
Journal:  Mass Spectrom Rev       Date:  2010 Jan-Feb       Impact factor: 10.946

8.  Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease.

Authors:  R M Villalba; T Wichmann; Y Smith
Journal:  Brain Struct Funct       Date:  2013-03-19       Impact factor: 3.270

Review 9.  The 6-hydroxydopamine model of Parkinson's disease.

Authors:  Nicola Simola; Micaela Morelli; Anna R Carta
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

Review 10.  Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.

Authors:  Caroline H Williams-Gray; Thomas Foltynie; Simon J G Lewis; Roger A Barker
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.